Requests that the FDA either (1) determine that NMN is not excluded from the definition of a dietary supplement under section 21 U.S.C. S321(ff)(3)(B) of the Act or (2) commit to exercise enforcement discretion in connection with the marketing and selling NMN in or as a dietary supplement
🏛 Food and Drug Administration (FDA)FDA-2023-P-0872
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.